MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,600,631 | -14.3% | 44,302 | -11.8% | 0.00% | 0.0% |
| Q1 2023 | $1,866,954 | -51.1% | 50,214 | -8.1% | 0.00% | -66.7% |
| Q3 2022 | $3,818,000 | +5.7% | 54,669 | +1.6% | 0.01% | +12.5% |
| Q2 2022 | $3,611,000 | +728.2% | 53,795 | +915.2% | 0.01% | +700.0% |
| Q1 2022 | $436,000 | -44.5% | 5,299 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $785,000 | -16.8% | 5,349 | +0.2% | 0.00% | -50.0% |
| Q3 2021 | $944,000 | -20.9% | 5,337 | -27.7% | 0.00% | -33.3% |
| Q2 2021 | $1,193,000 | -47.8% | 7,386 | -38.0% | 0.00% | -50.0% |
| Q1 2021 | $2,284,000 | +11.7% | 11,906 | +27.9% | 0.01% | +20.0% |
| Q4 2020 | $2,044,000 | -16.6% | 9,310 | -37.0% | 0.01% | -28.6% |
| Q3 2020 | $2,452,000 | +131.3% | 14,772 | +59.2% | 0.01% | +133.3% |
| Q2 2020 | $1,060,000 | +35.9% | 9,281 | -8.5% | 0.00% | 0.0% |
| Q1 2020 | $780,000 | -44.8% | 10,141 | -7.5% | 0.00% | -25.0% |
| Q4 2019 | $1,413,000 | +65.5% | 10,963 | +0.0% | 0.00% | +100.0% |
| Q3 2019 | $854,000 | -32.0% | 10,959 | -10.1% | 0.00% | -50.0% |
| Q2 2019 | $1,256,000 | -16.7% | 12,195 | -40.7% | 0.00% | -20.0% |
| Q1 2019 | $1,507,000 | +51.6% | 20,564 | +2.0% | 0.01% | +66.7% |
| Q2 2018 | $994,000 | – | 20,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |